SHIRE HUMAN GENETIC THERAPIES, INC.;THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
发明人:
Dennis KEEFE,Stephen ABMAN,Gregory SEEDORF
申请号：
US15564969
公开号：
US20180072805A1
申请日:
2016.04.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides, among other things, methods and compositions for treating chronic lung disorders, in particular, bronchopulmonary dysplasia (BPD). In some embodiments, a method according to the present invention includes administering to an individual who is suffering from or susceptible to BPD an effective amount of an anti-Flt-1 antibody, or antigen binding fragment thereof, such that at least one symptom or feature of BPD is reduced in intensity, severity, or frequency, or has delayed onset.
